BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25383876)

  • 1. The E6AP binding pocket of the HPV16 E6 oncoprotein provides a docking site for a small inhibitory peptide unrelated to E6AP, indicating druggability of E6.
    Zanier K; Stutz C; Kintscher S; Reinz E; Sehr P; Bulkescher J; Hoppe-Seyler K; Travé G; Hoppe-Seyler F
    PLoS One; 2014; 9(11):e112514. PubMed ID: 25383876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides.
    Stutz C; Reinz E; Honegger A; Bulkescher J; Schweizer J; Zanier K; Travé G; Lohrey C; Hoppe-Seyler K; Hoppe-Seyler F
    PLoS One; 2015; 10(7):e0132339. PubMed ID: 26151636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.
    Conrady MC; Suarez I; Gogl G; Frecot DI; Bonhoure A; Kostmann C; Cousido-Siah A; Mitschler A; Lim J; Masson M; Iftner T; Stubenrauch F; Travé G; Simon C
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53.
    Martinez-Zapien D; Ruiz FX; Poirson J; Mitschler A; Ramirez J; Forster A; Cousido-Siah A; Masson M; Vande Pol S; Podjarny A; Travé G; Zanier K
    Nature; 2016 Jan; 529(7587):541-5. PubMed ID: 26789255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential binding pocket on viral oncoprotein HPV16 E6: a promising anti-cancer target for small molecule drug discovery.
    Kolluru S; Momoh R; Lin L; Mallareddy JR; Krstenansky JL
    BMC Mol Cell Biol; 2019 Aug; 20(1):30. PubMed ID: 31387520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6.
    Zheng L; Ding H; Lu Z; Li Y; Pan Y; Ning T; Ke Y
    Genes Cells; 2008 Mar; 13(3):285-94. PubMed ID: 18298802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of papillomavirus E6 proteins with either MAML1 or E6AP clusters E6 proteins by structure, function, and evolutionary relatedness.
    Brimer N; Drews CM; Vande Pol SB
    PLoS Pathog; 2017 Dec; 13(12):e1006781. PubMed ID: 29281732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53.
    Zanier K; ould M'hamed ould Sidi A; Boulade-Ladame C; Rybin V; Chappelle A; Atkinson A; Kieffer B; Travé G
    Structure; 2012 Apr; 20(4):604-17. PubMed ID: 22483108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin induces G2 phase arrest and apoptosis with the activation of p53 in an E6 expression‑independent manner in HPV‑positive human cervical cancer‑derived cells.
    Clemente-Soto AF; Salas-Vidal E; Milan-Pacheco C; Sánchez-Carranza JN; Peralta-Zaragoza O; González-Maya L
    Mol Med Rep; 2019 Mar; 19(3):2097-2106. PubMed ID: 30664221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in silico appraisal of azoic and disulphide derivatives for anticancer activity against HPV E6 oncoprotein to medicate cervical cancer.
    Choudhury AD; Choudhury MD; Chetia P; Chowdhury A; Talukdar AD
    Comb Chem High Throughput Screen; 2014 Jan; 17(1):38-46. PubMed ID: 24164050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential localization of HPV16 E6 splice products with E6-associated protein.
    Vaeteewoottacharn K; Chamutpong S; Ponglikitmongkol M; Angeletti PC
    Virol J; 2005 Jun; 2():50. PubMed ID: 15960845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity.
    Drews CM; Brimer N; Vande Pol SB
    PLoS Pathog; 2020 Jan; 16(1):e1008295. PubMed ID: 31971989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance.
    Zanier K; Charbonnier S; Baltzinger M; Nominé Y; Altschuh D; Travé G
    J Mol Biol; 2005 Jun; 349(2):401-12. PubMed ID: 15890204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
    Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
    FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase.
    Kao WH; Beaudenon SL; Talis AL; Huibregtse JM; Howley PM
    J Virol; 2000 Jul; 74(14):6408-17. PubMed ID: 10864652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins.
    Zanier K; Charbonnier S; Sidi AO; McEwen AG; Ferrario MG; Poussin-Courmontagne P; Cura V; Brimer N; Babah KO; Ansari T; Muller I; Stote RH; Cavarelli J; Vande Pol S; Travé G
    Science; 2013 Feb; 339(6120):694-8. PubMed ID: 23393263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function.
    Cherry JJ; Rietz A; Malinkevich A; Liu Y; Xie M; Bartolowits M; Davisson VJ; Baleja JD; Androphy EJ
    PLoS One; 2013; 8(12):e84506. PubMed ID: 24376816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stability of the human papillomavirus E6 oncoprotein is E6AP dependent.
    Tomaić V; Pim D; Banks L
    Virology; 2009 Oct; 393(1):7-10. PubMed ID: 19700180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a PDZbody, a bivalent binder of the E6 protein from human papillomavirus.
    Karlsson OA; Ramirez J; Öberg D; Malmqvist T; Engström Å; Friberg M; Chi CN; Widersten M; Travé G; Nilsson MT; Jemth P
    Sci Rep; 2015 Mar; 5():9382. PubMed ID: 25797137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation.
    Jeong KW; Kim HZ; Kim S; Kim YS; Choe J
    Oncogene; 2007 Jan; 26(4):487-99. PubMed ID: 16878151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.